期刊文献+

siRNA抑制人胶质瘤细胞MDM2的表达及细胞增殖 被引量:1

siRNA Inhibits MDM2 Expression and Cell Proliferation in Glioma Cell Line
下载PDF
导出
摘要 目的研究siRNA对人胶质瘤U251细胞MDM2基因表达的抑制作用及对肿瘤细胞增殖和凋亡的影响。方法体外合成2对针对MDM2基因的siRNA,经脂质体转染导入U251细胞;用半定量RT-PCR检测siRNA MDM2对MDM2基因表达的抑制作用;并用MTT法检测siRNA MDM2对细胞增殖抑制作用,流式细胞仪检测细胞凋亡。结果转染siRNA MDM2的细胞的MDM2基因表达分别下调到对照组的31.61%和40.18%;转染阴性对照质粒的MDM2基因没有明显改变。MTT结果表明转染siRNA MDM2后细胞生长受到抑制,与对照组比差异具有显著性(P<0.5);同时细胞发生凋亡和细胞周期阻滞,转染siRNA MDM2-1,2的凋亡率分别为49.9%和40.0%,转染阴性对照质粒和对照组未检测出明显的增殖抑制和凋亡改变。结论 siRNA MDM2可以有效抑制U251细胞株中MDM2的表达,并抑制细胞增殖,诱导细胞凋亡。 Objective To study the inhibitory effect s of siRNA on MDM2 expression in glioma cell line U251 and cell proliferation.Methods siRNA targeting MDM2(PGCsilencer TM-MDM2-siRNA) was const ructed and transfercted into U251 cells.Meanwhile,cont rol siRNA was transfected and the transfection agent was used as the comparison.MDM2 gene expressions were measured using RT-PCR.Cell proliferation was measured with MTT assay.Results RT-PCR result showed that MDM2 mRNA expression levels were reduced to 31.61 % and 40.18 % after being transfected with siMDM2-1 and siMDM2-2;The difference between control siRNA and liposome group was not obvious(P0.05).The result s of MTT and flow cytometer showed that siRNA could suppress the proliferation and induce apoptosis of U251 cells.Conclusion siRNA can effectively down-regulate MDM2 expression in U251 cell line;inhibit the cell proliferation and induce apoptosis
出处 《中国实验诊断学》 北大核心 2011年第6期995-997,共3页 Chinese Journal of Laboratory Diagnosis
关键词 SIRNA MDM2 胶质瘤 逆转录聚合酶链反应 siRNA MDM2 glioma rverse tanscriptase polymerase chain reaction
  • 相关文献

参考文献9

  • 1Phan J, Li Z, Kasprzak A, et al. Structure-based design of high-affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX [ J ]. J Biol Chem,2009,12(12) : 1.
  • 2Pacinda SJ, L edet SC, Geondo MM, et al. p53 andMDM 2 immuno stain- ing in pulmonary blastomas and bronchogenic carcinomas [ J ]. Human Pathol, 1996,27 : 542.
  • 3Khatri RG, Navaratne K, Weil RJ. et al. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme[J]: J Neurosurg, 2008,109(5) : 842.
  • 4Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in so- matic nmmmalian cells using small interfering RNAs[J]. Methods,2002, 26(2) : 199.
  • 5Yu S, Qin D, Shangary S, et al. Potent and Orally Active Small-Molecule Inhibitors of the MDM2-p53 Interaction[ J]. J Med Chem, 2009,11 (24) : 16.
  • 6Lind H, Zienolddiny S, Ekstrom PO, Skaug Y, Haugen A. Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer[J]. Int J Cancer,2006,2(22):24.
  • 7Ichimura K, Bolin MB, Goike HM, et al. Deregulation of the pl4ARF/ MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1 - S transition control gene abnormalities[J]. Cancer Res, 2000, 60 (2) :417.
  • 8Park S, Hatanpaa KJ, Xie Y, et al. The receptor interacting protein 1 in- hibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma[ J]. Cancer Res, 2009,1 ;69(7) :2809.
  • 9吕佳音,吴丹凯,张舵舵,秦中国,吴丹华,赵燕颖.siRNA对骨肉瘤U2OS细胞株MDM2-mRNA表达的抑制作用[J].中国实验诊断学,2007,11(7):878-881. 被引量:2

二级参考文献1

共引文献1

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部